Research project
Caplacizumab in aTTP
Title
Real-life experience with caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura
Objective
To evaluate the effectiveness and safety of caplacizumab in patients diagnosed with acquired thrombotic thrombocytopenic purpura and to compare the results obtained with the treatments used in routine clinical practice.
Contact
- Marta Albanell
- Email malbanell@clinic.cat